Does Insurance Cover BRCA Testing? ACA, Medicare, Appeals

Does insurance cover BRCA testing? In most cases, yes. Non-grandfathered private health plans must cover BRCA risk assessment, genetic counseling, and the test itself with no copay, deductible, or coinsurance when you meet the eligibility criteria set by the U.S. Preventive Services Task Force. Medicare and Medicaid cover testing when it’s medically necessary. The gap between “fully covered” and “you owe thousands” usually comes down to whether you fit the criteria, whether your plan is subject to the ACA’s rules, and whether the paperwork gets done right.

Who Gets BRCA Testing Covered at No Cost

The Affordable Care Act requires non-grandfathered group and individual plans to cover preventive services with a USPSTF “A” or “B” rating without cost-sharing.1Office of the Law Revision Counsel. 42 U.S. Code 300gg-13 – Coverage of Preventive Health Services BRCA risk assessment, counseling, and testing carry a “B” rating for women who have a personal or family history of breast, ovarian, tubal, or peritoneal cancer, or ancestry associated with BRCA1/BRCA2 mutations.2United States Preventive Services Taskforce. Recommendation: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing If you fit, the plan must cover both the counseling and the test without charging you.

The process usually begins with a brief familial risk assessment at your primary care provider’s office. If that screening flags you, you’re referred for genetic counseling, and the counselor decides whether BRCA testing is appropriate. CMS has confirmed that the USPSTF recommendation covers both the counseling and the test when your provider determines the test is warranted.3Centers for Medicare & Medicaid Services. Affordable Care Act Implementation FAQs – Set 12

Who counts as “high-risk” is a clinical judgment, not a checkbox. Federal guidance says the attending provider decides. If your provider says you qualify, the plan must cover the service without cost-sharing, subject to reasonable medical management.3Centers for Medicare & Medicaid Services. Affordable Care Act Implementation FAQs – Set 12

Plans That Don’t Have to Follow the Rule

Grandfathered plans — those that existed before March 23, 2010, and haven’t made certain significant changes — are exempt from the ACA preventive services mandate. If your employer offers a grandfathered plan, BRCA testing could require cost-sharing or might not be covered at all. Your Summary of Benefits and Coverage will say whether the plan is grandfathered.

Self-funded employer plans, where the employer pays claims directly rather than buying insurance, are regulated under ERISA and generally must follow ACA preventive care requirements. They are exempt from state-level insurance mandates, though. Some states have expanded BRCA eligibility beyond the USPSTF criteria, but those broader rules typically won’t apply if your employer self-funds.

What About Men

The USPSTF recommendation addresses women, so the ACA’s no-cost-sharing mandate technically applies to women who meet the criteria. Men carry BRCA mutations too, and a mutation significantly increases the risk of prostate cancer, pancreatic cancer, and male breast cancer. The National Comprehensive Cancer Network recommends genetic testing regardless of sex for people with close blood relatives diagnosed with breast cancer at age 50 or younger, male breast cancer, ovarian cancer, pancreatic cancer, or high-risk prostate cancer. Many insurers follow NCCN guidelines alongside USPSTF criteria, so men with qualifying family histories often do get coverage. The difference is that the plan isn’t federally required to waive your cost-sharing, so you may still owe a copay or deductible.

Medicare and Medicaid

Medicare Part B covers BRCA1 and BRCA2 testing when it’s “reasonable and necessary for the diagnosis or treatment of illness or injury.” Medicare’s Local Coverage Determination looks for indicators like multiple BRCA-related cancers within a family, cancers appearing at earlier-than-typical ages, two or more primary cancers in one person, bilateral breast cancer, or male breast cancer. Triple-negative breast cancer is another strong indicator, since BRCA1 mutations show up in roughly 9 to 28 percent of those cases.4Centers for Medicare & Medicaid Services. LCD – BRCA1 and BRCA2 Genetic Testing (L36499)

Medicaid covers BRCA testing in nearly every state, though eligibility rules and the scope of coverage vary. Some state programs cover testing only for people already diagnosed with cancer; others cover it based on family history alone. If your Medicaid plan denies testing, a genetic counselor or patient navigator can often identify alternative pathways or financial assistance.

Preauthorization Can Make or Break the Claim

Even when you clearly meet the criteria, many plans require preauthorization before paying for BRCA testing. Skip this step and the claim may be denied outright, leaving you responsible for the full bill regardless of whether the test would otherwise have been covered.

Your healthcare provider typically handles the submission, sending clinical documentation that includes your family history, risk assessment results, the counselor’s recommendation, and how the test will influence your care. Approval can take anywhere from a few days to several weeks.

If preauthorization is denied, the insurer must give a reason. The most common ones are insufficient documentation of family history or a determination that you don’t meet the plan’s medical necessity threshold. Your provider can submit more evidence or request a peer-to-peer review, in which an insurance company physician discusses the case directly with your ordering doctor. These conversations often resolve denials faster than a formal appeal, so ask your provider to try one first.

If Your Claim Is Denied

Request the written Explanation of Benefits first. It spells out the specific denial reason and tells you what the appeal needs to address.

Internal Appeal

Federal rules give you 180 days from the denial notice to file an internal appeal. A strong appeal includes a letter of medical necessity from your provider, updated family history, counseling records, relevant clinical guidelines, and corrected billing information if a coding error caused the denial. For pre-service claims like testing that hasn’t happened yet, the insurer generally must respond within 30 days. Urgent claims get as little as 72 hours.

External Review

If the internal appeal fails, you can escalate to an external review, where an independent organization evaluates your case. Under the federal external review process, the reviewer must issue a standard decision within 45 days of receiving the request. For expedited reviews, typically when a delay could seriously jeopardize your health, the decision must come within 72 hours.5eCFR. 45 CFR 147.136 – Internal Claims and Appeals and External Review Processes The decision is binding on the insurer.

Check the Billing Code

Billing errors cause more BRCA denials than most people realize. The CPT codes include 81162, 81163, 81164, 81165, 81166, 81167, and others, depending on whether the test involves full sequencing, targeted analysis, or duplication/deletion analysis.6Centers for Medicare & Medicaid Services. Billing and Coding: BRCA1 and BRCA2 Genetic Testing If your provider’s office submitted the wrong code, or used one that was recently revised or deleted (CPT 81433 was removed effective January 2025), the claim will bounce. When you get a denial, always ask whether the code matched the actual test performed.

What Coverage Looks Like After a Positive Result

Getting the test paid for is only the first financial question. A positive result opens a cascade of follow-up decisions with their own coverage implications.

Enhanced surveillance, typically breast MRI alternating with mammography every six months, is generally covered when ordered based on documented high-risk status. The ACA’s preventive services rules cover breast cancer screening, and many plans extend this to include MRI for high-risk patients, though some classify the MRI as diagnostic rather than preventive, which triggers cost-sharing.

Prophylactic surgery is a harder question. No federal law specifically requires insurers to cover risk-reducing mastectomy or oophorectomy. Some states have mandated coverage for risk-reducing surgery in high-risk individuals, but coverage varies. Check with your insurer before scheduling anything. If you do undergo a mastectomy, whether prophylactic or therapeutic, the Women’s Health and Cancer Rights Act requires any plan that covers mastectomy to also cover breast reconstruction, surgery on the other breast for symmetry, prostheses, and treatment of physical complications like lymphedema.7Office of the Law Revision Counsel. 29 U.S. Code 1185b – Required Coverage for Reconstructive Surgery Following Mastectomies That coverage can be subject to your plan’s standard deductibles and coinsurance, but the plan cannot refuse the reconstructive services themselves.

What GINA Protects, and What It Doesn’t

A common fear is that a positive result could be used against you. The Genetic Information Nondiscrimination Act provides substantial protection in health insurance: group health plans cannot use genetic information to set premiums, deny coverage, or impose different contribution amounts based on your results.8U.S. Department of Labor, Employee Benefits Security Administration. Frequently Asked Questions Regarding the Genetic Information Nondiscrimination Act GINA also prohibits employment discrimination based on genetic information.

GINA does not cover life insurance, disability insurance, or long-term care insurance.9HHS.gov. Guidance on the Genetic Information Nondiscrimination Act (GINA) Companies selling those products can legally ask about genetic test results and use them in underwriting. If you’re thinking about purchasing any of those policies, consider doing so before you test. Genetic counselors routinely raise this, and it’s one of the most important planning steps people miss.

Paying Out of Pocket

If your insurance doesn’t cover testing, or covers only part of it, the out-of-pocket cost typically runs from $250 to $3,000, depending on whether you’re getting a targeted single-site test (checking for a specific mutation already identified in your family) or comprehensive full-gene sequencing with deletion/duplication analysis. A few years ago, comprehensive testing routinely ran $4,000 or more; competition among laboratories has pushed prices down.

Several laboratories run financial assistance programs with reduced pricing for uninsured patients or those whose insurance denied coverage. Income and eligibility thresholds differ, so being turned down by one lab doesn’t mean you won’t qualify at another. A genetic counselor or nurse navigator can help you identify which you’re most likely to qualify for. Some academic medical centers and research programs also offer free testing to eligible study participants.

HSA, FSA, and Tax Deductions

You can use funds from a Health Savings Account or Flexible Spending Arrangement to pay for testing. Genetic testing qualifies as a medical expense, defined by the IRS as costs for “diagnosis, cure, mitigation, treatment, or prevention of disease.”10Internal Revenue Service. Publication 502 (2025), Medical and Dental Expenses Without an HSA or FSA, unreimbursed genetic testing costs may be deductible on your federal tax return, but only if you itemize and your total medical expenses exceed 7.5% of your adjusted gross income for the year.11Internal Revenue Service. Topic No. 502, Medical and Dental Expenses For most people, that threshold is high enough that the deduction doesn’t help unless substantial other medical costs stack up in the same year.